Bayesian Capital Management, LP Ardelyx, Inc. Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 18,900 shares of ARDX stock, worth $80,702. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,900
Previous 50,400
62.5%
Holding current value
$80,702
Previous $260,000
64.62%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding ARDX
# of Institutions
235Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$107 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$64 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$47.6 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$43.5 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $660M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...